IS
IS · IS · IS-EU/1/22/1679/001
Opdualag
ATC L01FY02
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG*
CountryIS (IS)
ATC codeL01FY02
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "L01FY02",
"marketed": false,
"strength": "240 mg/80 mg",
"ma_number": "EU/1/22/1679/001",
"substance": "Nivolumabum INN,Relatlimabum INN",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "44819"
}Related drugs
Other records sharing ATC code L01FY02.
- PLOpdualagBristol-Myers Squibb Pharma EEIG
- 🇨🇭OpdualagBristol-Myers Squibb SA
- DKOpdualagBristol-Myers Squibb Pharma EEIG
- NOOpdualagBristol-Myers Squibb Pharma EEIG (1)
- FIOpdualagBristol-Myers Squibb Pharma EEIG
- CZOPDUALAGBristol-Myers Squibb Pharma EEIG, Dublin
- CAOPDUALAGBRISTOL-MYERS SQUIBB CANADA
- BEOpdualag 240 mg - 80 mgBristol-Myers Squibb Pharma
Access this data programmatically
Query Opdualag and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.